Evidence map›Paper›PMID 35983997›Full record

SynthesisPathogens and global health2023

Antimicrobial resistance among clinical

Qianxing Wu, Ali Zaman Vaziri, Nazanin Omidi, Vahab Hassan Kaviar, Abbas Maleki, Parand Khadivar, Ebrahim Kouhsari

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Pathogens and global health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Genome-wide investigation of outbreak-associatedFrontiers in microbiology · 2026
    Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Duped by dumping syndrome: non-endemicAccess microbiology · 2023
    Article
  10. Article
  11. Whole Genome Analysis of a Non-O1, Non-O139Infection and drug resistance · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Qianxing WuClinical Laboratory, Hainan Cancer Hospital, Haikou, Hainan, China.
Ali Zaman VaziriDepartment of Genetics, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
Nazanin OmidiClinical Microbiology Research Center, Ilam University of Medical Sciences, Ilam, Iran.
Vahab Hassan KaviarClinical Microbiology Research Center, Ilam University of Medical Sciences, Ilam, Iran.
Abbas MalekiClinical Microbiology Research Center, Ilam University of Medical Sciences, Ilam, Iran.
Parand KhadivarDepartment of Medical Biotechnology, Faculty of Advanced Technologies in Medicine, Golestan University of Medical Sciences, Gorgan, Iran.
Ebrahim KouhsariLaboratory Sciences Research Center, Golestan University of Medical Sciences, Gorgan, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-O1/non-O139

Indexed as

CholeraVibrio cholerae non-O1Anti-Bacterial AgentsChloramphenicolCiprofloxacinDrug Resistance, BacterialErythromycinGentamicinsHumansKanamycinMicrobial Sensitivity TestsTetracyclineTrimethoprim, Sulfamethoxazole Drug CombinationAnti-Bacterial AgentsChloramphenicolCiprofloxacinErythromycinGentamicinsKanamycinTetracyclineTrimethoprim, Sulfamethoxazole Drug CombinationAntibiotic resistancesystematic review and meta-analysisV. cholerae non-O1/non-O139

Identifiers

PMID35983997
PMCPMC10081078

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.